...
机译:血小板计数和血小板淋巴细胞比例作为头部和颈部鳞状细胞癌的预后标志:META分析
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
Department of Otorhinolaryngology ‐ Head and Neck SurgeryOsaka General Medical CenterOsaka Japan;
head and neck cancer; inflammation; lymphocyte; platelet; thrombocytosis;
机译:血小板计数和血小板淋巴细胞比例作为头部和颈部鳞状细胞癌的预后标志:META分析
机译:血小板计数,白蛋白和中性粒细胞淋巴细胞癌患者血小板复发性的预后价值
机译:作为预后标志物的鳞状细胞癌抗原和头部鳞状细胞癌中的临床病理特征相关性:系统评价和荟萃分析
机译:头颈鳞状细胞癌进展的新候选标记
机译:VEGF在头颈部鳞状细胞癌中的预后作用
机译:头颈部鳞状细胞癌患者血小板计数白蛋白和中性粒细胞淋巴细胞比值在局部复发的预后价值
机译:CD4 +和CD8 +肿瘤浸润性淋巴细胞头部和颈鳞状细胞癌的预后意义:META分析